Supporting the Wellness of Ontario Physicians During COVID-19

November 29, 2021 updated by: Ontario Medical Association
In light of the coronavirus pandemic, the challenge of physician burnout has taken on a new urgency. Long-hours and difficult, sometimes unsafe work conditions are creating a severe strain for emergency physicians and others on the frontlines of Ontario's response to COVID-19. There are a variety of evidence-informed ways that physicians can protect their wellbeing with modest investments of time and energy that will be applied. The evaluation will be a randomized trial comparing the outcomes from each of the three treatment arms. Researchers may also use a pre-post comparison with control parameters to conduct an exploratory analysis to assess efficacy.

Study Overview

Study Type

Interventional

Enrollment (Actual)

19124

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5S 3C1
        • Ontario Medical Association

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Active membership to the Ontario Medical Association (OMA). Up-to-date cell phone information registered to the OMA.

Exclusion Criteria:

  • Participation in the OMA Physician Burnout Task Force. Opt-out from the intervention.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Receive weekly SMS containing wellness stories shared by other Ontario physicians
Assessing the comparative effects of SMS types (storytelling; resources/strategies; and a combination of both) on physician wellbeing.
Experimental: Receive weekly SMS containing aim wellness resources/strategies.
Assessing the comparative effects of SMS types (storytelling; resources/strategies; and a combination of both) on physician wellbeing.
Experimental: Receive weekly SMS combining wellness stories & resources/strategies
Assessing the comparative effects of SMS types (storytelling; resources/strategies; and a combination of both) on physician wellbeing.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wellbeing (Short Warwick-Edinburgh Mental Well-being Scale measure)
Time Frame: 6 months
Self-reported wellbeing scores, as measured by the short Warwick-Edinburgh Mental Well-being Scale--(S)WEMWBS. The (S)WEMWBS is designed to measure positive mental wellbeing and asks people to what extent they agree with statements such as "I've been feeling optimistic about the future", "I've been feeling relaxed", and "I've been feeling close to people". This scale has a range of 7 to 35; higher scores indicate higher positive mental wellbeing.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Happiness (UK ONS measure)
Time Frame: 6 months
Self-reported happiness scores, as measured through weekly pulse surveys using a question developed by the UK Office for National Statistics (ONS) - hereby referred to as ONS-happiness ("on a scale where 0 is "not at all" and 10 is "completely", overall, how happy did you feel yesterday?"). This scale has a range from 0 to 10, with higher scores indicating greater happiness.
6 months
Anxiety (UK ONS measure)
Time Frame: 6 months
Self-reported anxiety scores, as measured through pulse surveys using an ONS question, hereby referred to as ONS-anxiety ("on a scale where 0 is "not at all" and 10 is "completely", overall, how anxious did you feel yesterday?"). This scale has a range from 0 to 10, with higher scores indicating greater anxiety.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: James Wright, Ontario Medical Association

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 26, 2021

Primary Completion (Actual)

September 2, 2021

Study Completion (Actual)

September 2, 2021

Study Registration Dates

First Submitted

February 8, 2021

First Submitted That Met QC Criteria

March 16, 2021

First Posted (Actual)

March 18, 2021

Study Record Updates

Last Update Posted (Actual)

November 30, 2021

Last Update Submitted That Met QC Criteria

November 29, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 39707

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Clinical Trials on Remote SMS (short message service, also known as "text message") delivery

Subscribe